TY - JOUR
T1 - Acute PKCδ inhibition limits ischaemia-reperfusion injury in the aged rat heart
T2 - Role of GSK-3β
AU - Kostyak, John C.
AU - Hunter, J. Craig
AU - Korzick, Donna H.
N1 - Funding Information:
The authors wish to thank Jennifer Novotny and Amy Simpson for their invaluable assistance with the graphic presentation of results. This project was supported by the following: KAI Pharmaceuticals (DHK), NIH KO1 AG00875 (DHK), NIH T32 GM008619 (JCH) and an American College of Sports Medicine Foundation Grant (JCK).
PY - 2006/5/1
Y1 - 2006/5/1
N2 - Objective: Age is a leading risk factor for the development of ischaemic heart disease and failure. However, the efficacy of cardioprotective strategies designed to rescue the aged myocardium remains controversial. We have previously demonstrated increased levels of basal cardiac protein kinase Cδ (PKCδ) with ageing, a well-known mediator of apoptotic cell death following ischaemia and reperfusion (I/R) in adult hearts. Our objective was to determine the contribution of PKCδ signaling mechanisms to reperfusion injury in the aged heart using local delivery of a novel PKCδ inhibitory peptide (KID1-1). Methods: Contractile responses were assessed in hearts isolated from adult (4 months, n = 38) and aged (24 months, n = 45) male Fisher 344 rats treated with either KID1-1 (500 nM) or Tat vehicle peptide (500 nM) upon reperfusion for 10 min following 31-min global ischaemia. Results: Recovery of left ventricular (LV) developed pressure was significantly improved by KID1-1 and associated with smaller infarct size in 24 months vs. age-matched controls (p < 0.005). We also observed significant reductions in DNA laddering and cytochrome c and caspase 3 levels in aged hearts treated with KID1-1. Interestingly, KID1-1 attenuated mitochondrial and nuclear PKCδ levels during reperfusion in aged vs. age-matched controls (p < 0.01). Further, increases in mitochondrial phosphorylated glycogen synthase kinase-3β (pGSK-3β) levels were hastened in aged and adult hearts following KID1-1 (p < 0.05), increasing the pGSK-3β/GSK-3β ratio. Conclusions: These results provide novel evidence for cardioprotection through acute PKCδ inhibition in aged rat heart following I/R. Our results also suggest, for the first time, a key role for mitochondrial GSK-3β as a cellular basis for the protection associated with PKCδ inhibition with ageing.
AB - Objective: Age is a leading risk factor for the development of ischaemic heart disease and failure. However, the efficacy of cardioprotective strategies designed to rescue the aged myocardium remains controversial. We have previously demonstrated increased levels of basal cardiac protein kinase Cδ (PKCδ) with ageing, a well-known mediator of apoptotic cell death following ischaemia and reperfusion (I/R) in adult hearts. Our objective was to determine the contribution of PKCδ signaling mechanisms to reperfusion injury in the aged heart using local delivery of a novel PKCδ inhibitory peptide (KID1-1). Methods: Contractile responses were assessed in hearts isolated from adult (4 months, n = 38) and aged (24 months, n = 45) male Fisher 344 rats treated with either KID1-1 (500 nM) or Tat vehicle peptide (500 nM) upon reperfusion for 10 min following 31-min global ischaemia. Results: Recovery of left ventricular (LV) developed pressure was significantly improved by KID1-1 and associated with smaller infarct size in 24 months vs. age-matched controls (p < 0.005). We also observed significant reductions in DNA laddering and cytochrome c and caspase 3 levels in aged hearts treated with KID1-1. Interestingly, KID1-1 attenuated mitochondrial and nuclear PKCδ levels during reperfusion in aged vs. age-matched controls (p < 0.01). Further, increases in mitochondrial phosphorylated glycogen synthase kinase-3β (pGSK-3β) levels were hastened in aged and adult hearts following KID1-1 (p < 0.05), increasing the pGSK-3β/GSK-3β ratio. Conclusions: These results provide novel evidence for cardioprotection through acute PKCδ inhibition in aged rat heart following I/R. Our results also suggest, for the first time, a key role for mitochondrial GSK-3β as a cellular basis for the protection associated with PKCδ inhibition with ageing.
UR - http://www.scopus.com/inward/record.url?scp=33646034941&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646034941&partnerID=8YFLogxK
U2 - 10.1016/j.cardiores.2006.02.009
DO - 10.1016/j.cardiores.2006.02.009
M3 - Article
C2 - 16542646
AN - SCOPUS:33646034941
SN - 0008-6363
VL - 70
SP - 325
EP - 334
JO - Cardiovascular Research
JF - Cardiovascular Research
IS - 2
ER -